Pernod Ricard SA (ETR:PER)

G1 Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	24,347	31,676	51,841	45,501	48,827	36,807
Market Cap Growth	-32.30%	-38.90%	13.93%	-6.81%	32.66%	-14.01%
Enterprise Value	37,462	44,082	61,972	53,724	57,134	45,265
Last Close Price	96.66	118.63	183.10	155.78	164.22	120.56
PE Ratio	22.19	21.46	22.92	22.80	37.42	111.88
PS Ratio	2.18	2.73	4.27	4.25	5.53	4.36
PB Ratio	1.38	1.89	3.10	2.80	3.24	2.59
P/FCF Ratio	22.32	33.20	38.95	25.45	31.18	45.11
P/OCF Ratio	13.22	18.34	25.50	19.84	24.43	31.17
EV/Sales Ratio	3.35	3.80	5.11	5.02	6.48	5.36
EV/EBITDA Ratio	11.16	12.86	16.51	17.14	22.09	18.16
EV/EBIT Ratio	12.82	14.22	18.57	17.83	23.75	20.02
EV/FCF Ratio	34.34	46.21	46.56	30.05	36.48	55.47
Debt / Equity Ratio	0.79	0.81	0.71	0.69	0.64	0.73
Debt / EBITDA Ratio	4.14	3.85	3.17	3.30	3.46	3.99
Debt / FCF Ratio	12.78	14.29	8.93	6.26	6.13	12.76
Asset Turnover	0.28	0.30	0.33	0.31	0.28	0.27
Inventory Turnover	0.54	0.56	0.63	0.61	0.56	0.56
Quick Ratio	0.66	0.64	0.54	0.71	0.86	0.70
Current Ratio	1.98	1.86	1.73	1.95	2.45	2.09
Return on Equity (ROE)	6.48%	9.04%	13.85%	12.97%	9.00%	2.32%
Return on Assets (ROA)	4.67%	5.04%	5.66%	5.53%	4.72%	4.52%
Return on Capital (ROIC)	5.93%	6.56%	7.44%	7.23%	6.10%	5.84%
Return on Capital Employed (ROCE)	8.90%	9.70%	10.90%	10.10%	8.60%	8.40%
Earnings Yield	4.51%	4.66%	4.36%	4.39%	2.67%	0.89%
FCF Yield	4.48%	3.01%	2.57%	3.93%	3.21%	2.22%
Dividend Yield	4.89%	3.96%	2.57%	2.65%	1.90%	2.21%
Payout Ratio	109.66%	81.84%	47.39%	41.38%	53.95%	258.06%
Buyback Yield / Dilution	0.96%	1.44%	1.09%	0.69%	0.96%	0.52%
Total Shareholder Return	5.85%	5.40%	3.66%	3.33%	2.86%	2.73%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.